Revolutionizing Parkinson’s detection with AI-driven eye tracking for earlier, more accurate diagnosis.
Early Detection Through AI-Driven Eye Tracking
In collaboration with the University of Michigan, we are identifying eye movement abnormalities as early indicators of Parkinson's disease, pioneering a new approach to early diagnosis.
Comprehensive Research Integration
By integrating large-scale data collection, neuro-mechanical assessments, and machine learning, we refine diagnostic accuracy and enhance patient care strategies through Clinical, Observational & Real-World Evidence.
Shaping the Future of Parkinson's Care
Our research supports clinical validation for FDA approvals, accelerating early intervention and transforming neurological health. Join us as a researcher, clinician, or participant and be part of the next breakthrough.
Join Our Parkinson's Research Study
Join the Future of Parkinson’s Research
Be part of the world’s largest Parkinson’s study, advancing early detection and treatment through AI-driven diagnostics. Whether you’re a clinician, researcher or a patient, your participation helps shape the future of neurological care.
Clinicians: Elevate Neurological Care
Integrate AI-powered diagnostics into your practice and be at the forefront of Parkinson’s research. Gain early access to cutting-edge technology, contribute clinical expertise, and help revolutionize early detection and patient outcomes.
Advance neurological healthcare through collaborative innovation. Your expertise matters.
Register
Simple online enrollment process takes less than five minutes.
Participate
Integrate cutting-edge diagnostic tools within your existing clinical workflow.
Contribute
Help refine AI algorithms through your clinical expertise and feedback.
Transform
Shape the future of neurological care for millions worldwide.
Researchers: Drive Innovation in Parkinson’s Research
Join a global effort to advance AI-driven diagnostics and transform early detection and treatment of Parkinson’s. Collaborate with leading experts, contribute valuable data, and help shape the future of neurological research and patient care.
Patients: Take Control of Your Brain Health
The World's Largest Parkinson's Study
Join our groundbreaking research using AI-driven analysis and real-world data to transform early Parkinson’s diagnosis.
Get involved as a researcher, clinician, or study participant and help shape the future of neurological care.
NeuroAI Research Centers
Clinical Trials
We conduct large-scale trials for neurological diagnostics. Our multi-center approach validates findings across diverse populations.
Technology Development
We design next-gen eye-tracking and neural assessment tools. Our engineering teams collaborate with leading neuroscientists worldwide.
Data Analysis Hub
We process neurological data using AI and machine learning. Our analytics infrastructure transforms findings into actionable clinical insights.
Research and Innovation
Advanced Studies
We invest in cutting-edge research and development.
Dedicated Team
Our researchers are pushing the boundaries of neurological diagnostics.
Future of Care
We are committed to improving neurological care through innovation.
Scientific Rigor
We ensure our results are reliable. Our approach is evidence-based.
Neurological Breakthroughs In Progress
- Concussion & TBI: AI-driven eye-tracking detects subtle injuries. Baseline comparisons ensure safe return-to-play decisions.
- Parkinson’s Disease: Early detection through oculomotor dysfunction. Tracks disease progression and therapy effectiveness.
- Alzheimer’s: Measures processing speed and cognitive function. Monitors early-stage impairments longitudinally.
- Vestibular Disorders: Balance testing identifies inner ear dysfunction. VOR assessments improve dizziness treatments.
- Stroke Recovery: Detects deficits with gaze tracking. AI-driven rehabilitation plans enhance recovery outcomes.
- Multiple Sclerosis: Tracks fatigue and motor impairments. Supports disease monitoring and treatment efficacy.
- Sports Injuries: Professional athlete testing ensures safe return-to-play. Includes baseline and recovery monitoring.
- Long COVID: Measures cognitive impairments and executive function. Tracks neuroinflammation’s impact on brain health.
Advancing Diagnostics of Neurological Disorders
as of March 14, 2025